Results 61 to 70 of about 830,210 (192)
ABSTRACT Alzheimer's disease (AD) is a progressive neurodegenerative disease, and cholinergic dysfunction is considered one of the fundamental pathological factors of this disease. Guided by the clinically used acetylcholinesterase (AChE) inhibitor donepezil, we explored trimetazidine dihydrochloride as an accessible starting scaffold to generate ...
Muhammed Oğuzhan Doğan +6 more
wiley +1 more source
This review offers a thorough examination of the therapeutic uses of hesperidin, emphasizes significant findings from structure‐activity relationship research, and addresses recent advancements in the synthesis and biological assessment of hesperidin analogs.
Mohammadsaeed Kordi +5 more
wiley +1 more source
This graphical abstract illustrates the effects of uncoated and coated mannitol supplementation on ruminal and fecal microbiomes, serum immune indices, antioxidant status, and metabolism in Sunit sheep. Neither uncoated nor coated mannitol altered growth performance.
Min Li +6 more
wiley +1 more source
Vocal Fold Atrophy in Patients With Alzheimer's Disease and Related Dementias
This is the first study to quantify vocal fold atrophy in patients with Alzheimer's disease and related dementias (AD/ADRD) using endoscopic imaging. Compared with age‐matched controls, AD/ADRD patients showed significantly greater vocal fold bowing and reduced mucosal wave amplitude, while normalized glottal gap area did not differ.
Byron Kim +5 more
wiley +1 more source
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He +4 more
wiley +1 more source
Alzheimer's Disease: Mechanisms and Therapeutic Advances
Alzheimer's disease involves Aβ/tau aggregation, neuroinflammation, BBB leakage, gut–brain dysfunction, and mitochondrial damage, causing neuronal loss. Nanodelivery enables combined small‐molecule and targeted therapies. Disease‐modifying biologics/chemicals, including anti‐Aβ antibodies, raise safety and access concerns. Exercise, cognitive training,
Gaoshuang Fu +4 more
wiley +1 more source
Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction remains a diagnostic and methodological challenge.
Indira Garcia‐Cordero +12 more
wiley +1 more source
Natural cholinesterase inhibitors from marine organisms
Covering: Published between 1974 up to 2018Inhibition of cholinesterases is a common approach for the management of several disease states. Most notably, cholinesterase inhibitors are used to alleviate the symptoms of neurological disorders like dementia
Svenson, Johan +8 more
core +1 more source

